1. Home
  2. CNTX vs VIDA Comparison

CNTX vs VIDA Comparison

Compare CNTX & VIDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Context Therapeutics Inc.

CNTX

Context Therapeutics Inc.

HOLD

Current Price

$0.48

Market Cap

57.2M

Sector

Health Care

ML Signal

HOLD

VIDA

VIDA Global Inc. Class A Common Stock

N/A

Current Price

$2.44

Market Cap

64.7M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CNTX
VIDA
Founded
2015
N/A
Country
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
57.2M
64.7M
IPO Year
2021
2026

Fundamental Metrics

Financial Performance
Metric
CNTX
VIDA
Price
$0.48
$2.44
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$6.60
N/A
AVG Volume (30 Days)
2.2M
98.2K
Earning Date
05-08-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
17.39
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.49
$2.06
52 Week High
$3.62
$4.25

Technical Indicators

Market Signals
Indicator
CNTX
VIDA
Relative Strength Index (RSI) 32.19 35.83
Support Level N/A $2.17
Resistance Level $0.68 $2.88
Average True Range (ATR) 0.05 0.33
MACD 0.03 0.03
Stochastic Oscillator 8.78 13.97

Price Performance

Historical Comparison
CNTX
VIDA

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Share on Social Networks: